# BioNexus Gene Lab Corp: Form 8-K, filed Feb 14, 2025

- Company: [BioNexus Gene Lab Corp](/companies/bglc.md) (CIK 1737523)
- Form: 8-K
- Filed: 2025-02-14
- Accepted by EDGAR: Feb 14, 2025, 22:20 ET
- Period: 2025-02-11
- Accession: 0001477932-25-001063
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737523/000147793225001063/bglc_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737523/000147793225001063/

## Items reported

- Item 3.02: Unregistered sale of equity
- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737523/000147793225001063/bglc_8k.htm

Filed Feb 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001477932-25-001063. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.